EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure

Claire Xiao, Lucy MacDonald, Slava Epelman, Kory J Lavine

Immunological Reviews · 2026-07 · 340 (1)

DOI: 10.1111/imr.70137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 20.06.2026. Verfasst von Claire Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Macrophages, Heart Failure, Cell Plasticity, Myocardial Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophages, as central effectors of innate immunity, play context‐specific and time‐dependent roles in myocardial infarction (MI) and in the pathogenesis of ischemic heart failure (HF). Their plasticity, heterogeneity, and interactions with other cardiac and immune cells determine whether inflammation resolves and repair ensues, or maladaptive remodeling culminates in ventricular dysfunction. In this review, we synthesize findings from lineage‐tracing studies, single‐cell transcriptomic atlases, and clinical trials to highlight macrophage ontogeny, recruitment, reparative programs, and pathogenic functions in chronic remodeling. We discuss embryonically‐derived cardiac resident macrophages, recruitment of monocyte‐derived macrophages and their respective roles after ischemic injury, and how efferocytotic clearance of cellular and mitochondrial debris is a key component of the reparative response. We highlight macrophage interactions with cardiomyocytes, fibroblasts, neutrophils, T cells, and conduction system cells, and outline translational strategies involving chemokine pathway inhibition and specialized pro‐resolving mediators. Mechanistic insight into macrophage ontogeny, heterogeneity, and intercellular interactions has uncovered novel therapeutic possibilities. Targeted, temporally staged macrophage therapies, using biomarkers and imaging for patient stratification, may improve post‐MI healing and prevent progression toward ischemic HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesHeart FailureCell PlasticityMyocardial IschemiaHumansAnimalsVentricular RemodelingImmunity, InnateCell Communication

Stichwörter der Autor:innen

cardiac remodelingheterogeneityischemic heart failuremacrophagemyocardial infarctionsingle‐cell RNA sequencing

Autor:innen und Institutionen

  • Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Peter Munk Cardiac Centre Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Ted Rogers Centre for Heart Research, Translational Biology and Engineering Program, Toronto, Ontario, Canada.
  • Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Immunology and Pathology, Washington University School of Medicine, St. Louis, Missouri, USA.

Zitieren

APA

Xiao, C., MacDonald, L., Epelman, S., & Lavine, K. J. (2026). Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure. Immunological Reviews, 340(1). https://doi.org/10.1111/imr.70137

Vancouver

Xiao C, MacDonald L, Epelman S, Lavine KJ. Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure. Immunological Reviews. 2026;340(1). doi:10.1111/imr.70137

BibTeX
@article{Xiao2026,
  author = {Xiao, Claire and MacDonald, Lucy and Epelman, Slava and Lavine, Kory J},
  title = {Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure},
  journal = {Immunological Reviews},
  year = {2026},
  volume = {340},
  number = {1},
  doi = {10.1111/imr.70137}
}
Kostenlos starten →